Thermo Fisher Scientific Inc (TMO)

TMO (NYSE:Health Services) EQUITY
$182.16
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | TMO Avg Daily Volume: 1,410,500
Last Update: 07/24/17 - 4:02 PM EDT
Volume: 0
YTD Performance: 29.10%
Open: $0.00
Previous Close: $182.16
52 Week Range: $139.07 - $182.87
Oustanding Shares: 391,219,918
Market Cap: 71,272,444,661
6-Month Chart
TheStreet Ratings Grade for TMO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 12
Moderate Buy 0 0 0 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.17 1.15 1.15 1.18
Latest Dividend: 0.15
Latest Dividend Yield: 0.33%
Dividend Ex-Date: 09/14/17
Price Earnings Ratio: 33.18
Price Earnings Comparisons:
TMO Sector Avg. S&P 500
33.18 33.20 30.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
15.77% 16.11% 45.14%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.40 0.12
Net Income 2.30 0.60 0.16
EPS 3.50 0.50 0.13
Earnings for TMO:
EBITDA 4.40B
Revenue 18.27B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $2.26 $2.25 $9.23 $10.28
Number of Analysts 11 9 12 11
High Estimate $2.28 $2.28 $9.28 $10.81
Low Estimate $2.22 $2.21 $9.20 $10.03
Prior Year $2.03 $2.03 $8.27 $9.23
Growth Rate (Year over Year) 11.37% 10.73% 11.60% 11.37%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA

updateCantor Fitzgerald Initiates Thermo Fisher as Overweight

May 19, 2017 | 9:17 AM EDT

Thermo Fisher stock coverage was initiated at Cantor Fitzgerald with an "Overweight" rating and a $194 price target.

RMPIA
By

Bruce Kamich

 | May 8, 2017 | 11:20 AM EDT
The stock could reach $200.
RMPIA
By

Jim Cramer

 | May 8, 2017 | 6:27 AM EDT
It's a wonder to me how split this market really is.
RMPIA
By

David Katz

 | Jan 27, 2017 | 8:00 AM EST
Value stocks will extend their outperformance over growth stocks that began last year.
RMPIA
By

Robert Moreno

 | Jan 9, 2017 | 10:46 AM EST
Thermo Fisher Scientific and IHS Markit are both breaking out of tight patterns.
RMPIA

bearishThermo Fisher cut from Conviction Buy List at Goldman

Dec 12, 2016 | 7:35 AM EST
TMO was removed from the Conviction Buy list, according to Goldman Sachs. $168 price target. Company lacks near-term catalysts.
RMPIA
By

Bruce Kamich

 | Nov 28, 2016 | 2:57 PM EST
Approach with caution.
RMPIA
By

Guy Ortmann

 | Nov 28, 2016 | 11:36 AM EST
Charts showing up or down trends in the past week.
RMPIA
By

Jim Cramer and the AAP Team

 | Nov 4, 2016 | 10:00 AM EDT
We strongly recommend members avoid any temptation to trade around political events.
RMPIA
By

Doug Kass

 | Oct 10, 2016 | 6:18 PM EDT
Back from my meetings to find the S&P 500 Index basically traded in a 2-3 point range over the last four hours, which is a statisti …
Ahead of Wednesday's earnings report(pre open)GD is on its way to its best close of the ye...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.